Aurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also developing weight loss drugs. Future growth will come from more product launches and a recent acquisition. Backward integration projects are also boosting profitability. The company expects strong earnings growth.
US stocks today: US market ends higher, S&P 500, Nasdaq notch biggest monthly gains in years
U.S. stocks surged on Thursday, with the S&P 500 and Nasdaq achieving their largest monthly gains in years. Strong corporate earnings, particularly from tech giants